Change of https://www.gov.uk/government/publications/live-attenuated-influenza-vaccine-patient-group-direction-pgd-template

Change description : 2025-08-13 10:13:00: Added information about the addendum. [Guidance and regulation]

Showing diff : 2025-08-08 08:30:34.754492537 +00:00..2025-08-13 09:13:12.370692544 +00:00

Guidance

Live attenuated flu vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated flu vaccine (Fluenz Trivalent®) in accordance with national seasonal flu vaccination programme

From:
UK Health Security Agency
Published
10 July 2024
Last updated
813 August 2025 — See all updates

Applies to England

Documents

Influenza vaccine (Fluenz Trivalent®): patient group direction (PGD) template

MS Word Document, 1.43 MB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Addendum to: live attenuated influenza vaccine nasal spray suspension (LAIV) patient group direction (PGD)

MS Word Document, 155 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of the national seasonal influenza vaccination programme.

LAIV PGD version 15.00 is valid from 1 September 2025 to 1 April 2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

The Addendum to UKHSA LAIV PGD version 15.0 GOV-18720 should be used in conjunction with the fully authorised UKHSA LAIV PGD version 15.0 GOV-18720.  

The addendum provides the current strain formulation as per the Fluenz® nasal spray suspension Influenza vaccine updated Summary of product characteristics (SPC) dated 21 July 2025. Please refer to the Summary of product characteristics for the full details of the formulation.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of product characteristics for the vaccine.

Updates to this page

Published 10 July 2024
Last updated 813 August 2025 + show all updates

  1. Added information about the addendum.

  2. Added 'Addendum to: Live attenuated influenza vaccine nasal spray suspension (LAIV) Patient Group Direction (PGD)'

  3. Added version 15, see page 4 for change history.

  4. First published.

Sign up for emails or print this page

Update history

2025-08-13 10:13
Added information about the addendum.

2025-08-08 09:30
Added ‘Addendum to: Live attenuated influenza vaccine nasal spray suspension (LAIV) Patient Group Direction (PGD)’

2025-07-01 12:00
Added version 15, see page 4 for change history.

2024-07-10 11:00
First published.